GTCbio is proud to present the Stem Cell Summit 2017, to be held on April 5-7, 2017 in Boston, MA. GTCbio's Stem Cell Summit provides cutting-edge information on developments in all areas of stem cell research from bench to bedside, including the biology, medicine, applications, regulations, product development, and the commercialization of stem cells.

Recent developments in pre-clinical and clinical trials of stem cell therapy, regenerative medicine and tissue engineering, cancer stem cells, immunotherapy, stem cell reprogramming, regulatory policies regarding stem cell research, and manufacturing will all be discussed. Business opportunities, challenges, and potential strategies for overcoming these challenges will also be addressed. Come join us to learn what categories of companies are currently commercially viable, how they're being funded, and what kind of strategic relationships are available within the industry!

Stem Cell Summit 2017 includes two back-to-back conferences including joint plenary session

Conference 1: 14th Stem Cell Research & Regenerative Medicine
I. Advances in Adult & Pluripotent Stem Cell Research
II. Revolution in Immunotherapy: Car T-Cells
III. Translation to the Clinic: What's in the Pipeline

Joint: Plenary Session
I. Where do We Stand with Stem Cell Therapy in Diabetes?
Conference 2: 6th Stem Cell Product Development & Commercialization
I. Stem Cells for Drug Discovery & Disease Modeling
II. Regulatory Challenges in Cell Therapy
III. Manufacturing and Scalable Processes
IV. Commercialization: Creating Sustainable Business Models
V. Funding and Partnering
VI. Frontiers in Tissue Engineering